The MDM2 oncogene is rarely amplified in human lymphoid tumors and does not correlate with p53 gene expression
- 1 February 1994
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 56 (3), 457-458
- https://doi.org/10.1002/ijc.2910560329
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutationsBlood, 1992
- Amplification of a gene encoding a p53-associated protein in human sarcomasNature, 1992
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- p53 mutations in colorectal cancer.Proceedings of the National Academy of Sciences, 1990
- Increased expression of mutant forms of p53 oncogene in primary lung cancerThe Lancet, 1990
- Stabilization of the p53 transformation-related protein in mouse fibrosarcoma cell lines: effects of protein sequence and intracellular environment.Molecular and Cellular Biology, 1989
- Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.Molecular and Cellular Biology, 1988
- Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas.The Journal of Experimental Medicine, 1986
- Increased expression of p53 protein in human leukemia cells.Proceedings of the National Academy of Sciences, 1986
- A monoclonal antibody detecting the adenovirus type 5 E 1 b-58Kd tumor antigen: Characterization of the E 1 b-58Kd tumor antigen in adenovirus-infected and -transformed cellsVirology, 1982